New function of CRISPR gene scissors discovered
For several years, the CRISPR/Cas9 gene scissors have been causing a sensation in science and…
November 25, 2022 - 3 minutes
Germany
What recent mixed clinical results can teach about Alzheimer’s disease
2022 has provided mixed fortunes for companies aiming to slow Alzheimer’s disease. Ulrich Dauer, CEO…
November 23, 2022 - 7 minutes
Concern as study says new covid sub-variant is resistant to all therapeutic antibodies
All approved antibody therapies for Covid-19 are ineffective against the Omicron sub-lineage BQ.1.1. That’s the…
November 23, 2022 - 4 minutes
CatalYm raises €50M to boost solid tumors trial
CatalYm has announced the close of a €50 million ($49 million) series C financing round. …
November 22, 2022 - 2 minutes
Beyond Biotech podcast 23: World Antimicrobial Awareness Week, PsychoGenics
This week, we have three interviews on the theme of antimicrobial resistance (AMR), to mark…
November 18, 2022 - 3 minutes
FundaMental Pharma launches with €10M to advance first-in-class neuroprotectant
FundaMental Pharma GmbH, a preclinical neuroscience company spun out of Heidelberg University in Germany, has…
November 17, 2022 - 2 minutes
InfanDx tackles early detection of hypoxic ischemic encephalopathy
InfanDx AG, a privately held diagnostics company focusing on the development and commercialization of novel…
November 14, 2022 - 8 minutes
Researchers develop new nanoparticle to deliver drugs direct to macrophages
How can a drug be delivered exactly where it is needed, while limiting the risk…
November 10, 2022 - 4 minutes
New radiopharmaceutical shrinks prostate cancer tumors
Researchers in Japan and Germany say a radiopharmaceutical treatment targeting a prostate-specific membrane antigen effectively…
November 10, 2022 - 3 minutes
Does covid vaccination boost cancer treatment?
Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against…
November 8, 2022 - 2 minutes
Centogene launches rare and neurodegenerative disease Biodata Network
German company, Centogene N.V., today (November 4) announced its launch of Biodata Network, a portfolio…
November 4, 2022 - 3 minutes
Breakpoint Therapeutics sabotages DNA repair in cancer cells
The Hamburg-based Evotec spinout Breakpoint Therapeutics is working on cancer treatments that block the ability…
November 2, 2022 - 4 minutes
